tiprankstipranks
PW Medtech Group Ltd. (HK:1358)
:1358
Hong Kong Market
1358
PW Medtech Group Ltd.
RESEARCH TOOLSreports
Want to see HK:1358 full AI Analyst Report?

PW Medtech Group Ltd. (1358) Ratios

1 Followers

PW Medtech Group Ltd. Ratios

HK:1358's free cash flow for Q4 2025 was ¥0.48. For the 2025 fiscal year, HK:1358's free cash flow was decreased by ¥ and operating cash flow was ¥0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 10.89 10.89 11.80 13.61 11.59
Quick Ratio
 10.22 10.22 11.12 12.70 10.81
Cash Ratio
 8.32 8.32 9.48 10.65 8.23
Solvency Ratio
 0.62 0.64 0.69 0.77 0.52
Operating Cash Flow Ratio
 0.72 1.11 1.79 1.41 1.60
Short-Term Operating Cash Flow Coverage
 9.11 13.95 0.00 0.00 0.00
Net Current Asset Value
¥ 2.00B¥ 2.00B¥ 1.74B¥ 1.70B¥ 1.59B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 <0.01 0.00 0.00
Financial Leverage Ratio
 1.33 1.33 1.30 1.27 1.26
Debt Service Coverage Ratio
 12.62 12.97 624.97 1.97K 315.97
Interest Coverage Ratio
 317.28 169.86 479.90 1.22K 264.75
Debt to Market Cap
 0.01 <0.01 <0.01 0.00 0.00
Interest Debt Per Share
 0.01 0.02 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -7.06 -6.78 -6.16 -4.82 -7.85
Profitability Margins
Gross Profit Margin
49.48%49.48%54.55%56.42%55.67%
EBIT Margin
15.14%15.27%22.63%34.25%18.29%
EBITDA Margin
30.64%31.92%35.24%48.81%32.69%
Operating Profit Margin
14.85%14.85%23.34%27.76%22.88%
Pretax Profit Margin
20.04%20.04%29.88%34.23%29.39%
Net Profit Margin
11.46%11.46%19.61%22.69%19.75%
Continuous Operations Profit Margin
16.42%16.42%25.04%30.37%24.01%
Net Income Per EBT
57.20%57.20%65.63%66.29%67.22%
EBT Per EBIT
134.91%134.91%128.01%123.30%128.41%
Return on Assets (ROA)
1.80%1.80%2.92%2.97%2.13%
Return on Equity (ROE)
2.37%2.39%3.80%3.79%2.69%
Return on Capital Employed (ROCE)
2.44%2.44%3.60%3.75%2.55%
Return on Invested Capital (ROIC)
1.99%1.99%3.02%3.32%2.65%
Return on Tangible Assets
2.58%2.58%4.27%3.63%2.63%
Earnings Yield
6.00%5.39%10.40%13.00%12.17%
Efficiency Ratios
Receivables Turnover
 2.15 2.15 8.28 6.15 6.01
Payables Turnover
 7.07 7.07 8.36 7.56 8.55
Inventory Turnover
 2.86 2.86 2.91 2.15 1.80
Fixed Asset Turnover
 0.88 0.88 0.83 0.72 0.56
Asset Turnover
 0.16 0.16 0.15 0.13 0.11
Working Capital Turnover Ratio
 0.38 0.41 0.40 0.37 0.25
Cash Conversion Cycle
 245.37 245.37 126.09 180.52 220.77
Days of Sales Outstanding
 169.53 169.53 44.10 59.32 60.68
Days of Inventory Outstanding
 127.44 127.44 125.63 169.49 202.79
Days of Payables Outstanding
 51.60 51.60 43.65 48.29 42.70
Operating Cycle
 296.97 296.97 169.73 228.81 263.47
Cash Flow Ratios
Operating Cash Flow Per Share
 0.10 0.16 0.21 0.13 0.17
Free Cash Flow Per Share
 0.07 0.09 0.16 0.08 0.14
CapEx Per Share
 0.03 0.07 0.05 0.05 0.03
Free Cash Flow to Operating Cash Flow
 0.70 0.56 0.77 0.61 0.81
Dividend Paid and CapEx Coverage Ratio
 0.90 1.02 1.54 1.37 5.13
Capital Expenditure Coverage Ratio
 3.33 2.29 4.42 2.58 5.13
Operating Cash Flow Coverage Ratio
 7.14 10.94 26.37 187.08 63.48
Operating Cash Flow to Sales Ratio
 0.19 0.29 0.41 0.31 0.50
Free Cash Flow Yield
7.39%7.75%16.99%10.96%24.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 16.66 18.55 9.61 7.69 8.22
Price-to-Sales (P/S) Ratio
 1.81 2.13 1.89 1.74 1.62
Price-to-Book (P/B) Ratio
 0.40 0.44 0.37 0.29 0.22
Price-to-Free Cash Flow (P/FCF) Ratio
 13.53 12.91 5.88 9.12 4.02
Price-to-Operating Cash Flow Ratio
 10.00 7.27 4.55 5.58 3.24
Price-to-Earnings Growth (PEG) Ratio
 -0.47 -0.51 -94.03 0.17 -0.10
Price-to-Fair Value
 0.40 0.44 0.37 0.29 0.22
Enterprise Value Multiple
 -1.16 -0.12 -0.81 -1.25 -2.89
Enterprise Value
 -292.25M -30.95M -220.30M -410.57M -506.46M
EV to EBITDA
 -1.16 -0.12 -0.81 -1.25 -2.89
EV to Sales
 -0.35 -0.04 -0.29 -0.61 -0.94
EV to Free Cash Flow
 -2.66 -0.23 -0.89 -3.18 -2.34
EV to Operating Cash Flow
 -1.86 -0.13 -0.69 -1.95 -1.88
Tangible Book Value Per Share
 2.15 2.18 2.05 2.49 2.35
Shareholders’ Equity Per Share
 2.57 2.62 2.57 2.58 2.52
Tax and Other Ratios
Effective Tax Rate
 0.18 0.18 0.16 0.11 0.18
Revenue Per Share
 0.54 0.55 0.50 0.43 0.34
Net Income Per Share
 0.06 0.06 0.10 0.10 0.07
Tax Burden
 0.57 0.57 0.66 0.66 0.67
Interest Burden
 1.32 1.31 1.32 1.00 1.61
Research & Development to Revenue
 0.06 0.06 0.06 0.06 0.08
SG&A to Revenue
 0.32 0.33 0.31 0.18 0.23
Stock-Based Compensation to Revenue
 0.00 0.00 0.02 0.00 0.00
Income Quality
 1.71 2.62 1.39 0.91 2.54
Currency in CNY